Professional
Added to YB: 2025-02-11
Pitch date: 2024-12-31
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+106.03%
current return
Author Info
No bio for this author
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 19.21
Price Target
N/A
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
turnaround
Oakmark Global All Cap Strategy Portfolio Holding: Bayer
BAYN.DE: Stock down on PCB litigation review & soft 2025 guidance. Crop protection profit decline disappointing. New CEO's restructuring may offset pressures. Well-positioned franchises have potential. Watching for evidence of success in Anderson's strategy Year 2.
Read full article (1 min)